Merck spends $10 billion for Verona, gaining access to its COPD medication

5 months ago 199
Pharmaceutical elephantine Merck is buying Verona Pharma, a institution that focuses connected respiratory diseases, successful an astir $10 cardinal deal.
Read Entire Article